AKT1 and breast cancer: In BALB/c female nude mice with MDA-MB-231 or -453 cells, 6-MSITC decreased the level of phosphorylated AKT in a dose-dependent manner, thus inhibiting the NF-κB pathway and promoting the apoptosis of breast cancer cells [30].